Rare diseases
Investigational molecules
Locations
281 Tresser Boulevard Floor 9th, 06901-3238, United States
Clinical research in CLL/SLL centers on pirtobrutinib and related Bruton’s tyrosine kinase-targeted approaches for patients with previously treated disease, untreated disease, and BTK-inhibitor exposure.
Studies also include comparisons with bendamustine plus rituximab and idelalisib-based regimens in relapsed or refractory settings.
Loxo Oncology Inc. runs clinical trials in conditions such as Chronic lymphocytic leukaemia, Medullary thyroid cancer, Neoplasm, Non-small cell lung cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
DenmarkAustria
BelgiumAustria
FranceDenmarkAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
